Adding Radiotherapy to Adjuvant Chemotherapy Improves OS in Stage IV Endometrial Cancer
The greatest benefit was observed when chemotherapy was combined with external beam radiation therapy and vaginal brachytherapy.
The greatest benefit was observed when chemotherapy was combined with external beam radiation therapy and vaginal brachytherapy.
A retrospective review sought to better understand the relationship between bortezomib and lenalidomide therapy and treatment-induced skin rash in multiple myeloma.
Neoadjuvant chemotherapy response rates differed among patients with genomically unstable bladder tumors, urothelial-like bladder tumors, and basal/squamous subtypes.
Progression on bacillus Calmette-Guérin (BCG) likely represents a biologically aggressive disease state as well as diagnostic delay, according to investigators.
Findings refute the notion that variant histology MIBC will not respond to neoadjuvant chemotherapy.
Investigators sought to determine if same-day administration of prophylactic pegfilgrastim was as effective as next-day administration.
Researchers identified patterns around usage of scalp cooling therapy to reduce the risk of chemotherapy-induced alopecia in patients.
Real-world data validate recently reported findings from clinical trials.
There was no significant difference in the risk of hypersensitivity reactions with low-dose or high-dose dexamethasone.
Risk for thrombosis doubled if catheter-to-vein ratio exceeds 45 percent for peripherally inserted central catheter.